The First GLP-1 Pill Costs $149 a Month and Changes Everything About Obesity Treatment
Eli Lilly's Foundayo pill hit pharmacies this week at $149/month — a fraction of injectable GLP-1 costs — and could reach millions who refused the needle.
Nora Whitfield
Bureau: Chicago
Semaglutide Users Were 42 Percent Less Likely to Be Hospitalized for Mental Health Conditions
A 100,000-patient study found GLP-1 drugs slashed depression risk by 44%, anxiety by 38%, and substance-use hospitalizations by 47%.
The United States Has Recorded 1,671 Measles Cases This Year, and the Worst Outbreak Is in a County Most Americans Cannot Find on a Map
South Carolina alone accounts for nearly 1,000 of the nation's 1,671 measles cases, with 94% of patients unvaccinated and kindergarten MMR rates below herd immunity.
The Male Birth Control Breakthrough That No Pharma Company Will Fund
Cornell researchers stopped sperm production in mice by targeting meiosis — fully reversible in six weeks — but no company has committed to Phase 3.
H5N1 Is Jumping Species in New York City and Nobody Is Treating It Like an Emergency
H5N1 bird flu is infecting raccoons, foxes, feral cats, and raptors across NYC while 990 humans have been infected globally.